Yesterday, the Food and Drug Administration (FDA) announced that it would be taking steps towards considering a new regulatory framework tailored to promote developing safe and effective medical devices that use artificial intelligence algorithms.

IBM signed a research initiative with the Food and Drug Administration to research whether blockchain technology can be used to securely record and share medical data.

In order to better provide opioid users with ready access to life-saving medication in the case of an overdose, the U.S. Food and Drug Administration announced that it would be hosting a 2016 Naloxone App Competition.